Neuroprotective and ameliorative actions of polyunsaturated fatty acids against neuronal diseases: Beneficial effect of docosahexaenoic acid on cognitive decline in Alzheimer's disease

Journal of Pharmacological Sciences

Volumn 116, Issue 2, 2011, Pages 150-162

  Hashimoto, Michio ^a   Hossain, Shahdat ^a,b  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^b JAHANGIRNAGAR UNIVERSITY   (Bangladesh)

Author keywords

Alzheimer's disease; Amyloid fibrillation; Docosahexaenoic acid; Neurogenesis; Neuronal toxicity; Oxidative stress; Polyunsaturated fatty acid

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; DOCOSAHEXAENOIC ACID; LIPID PEROXIDE; POLYUNSATURATED FATTY ACID; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; AMYLOIDOSIS; APOPTOSIS; COGNITIVE DEFECT; DIET SUPPLEMENTATION; DISEASE SEVERITY; ESSENTIAL FATTY ACID DEFICIENCY; GLUCOSE TRANSPORT; HIPPOCAMPUS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LEARNING DISORDER; LIPID ANALYSIS; LIPID RAFT; MEMORY DISORDER; MENTAL DETERIORATION; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN POLYMERIZATION; PROTEIN SYNTHESIS INHIBITION; SHORT SURVEY;

EID: 79959361405     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.10R33FM     Document Type: Short Survey

References (122)

1. Rapoport SI, Rao JS, Igarashi M. Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver. Prostaglandins Leukot Essent Fatty Acids. 2007;77:251-261. (Pubitemid 350214520)
2. Lauritzen L, Hansen HS, Jørgensen MH, Michaelsen KF. The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog Lipid Res. 2001;40:1-94. (Pubitemid 32008650)
3. Moore SA. Polyunsaturated fatty acid synthesis and release by brain-derived cells in vitro. J Mol Neurosci. 2001;16:195-200. (Pubitemid 32664779)
4. Bourre JM, Francois M, Youyou A, Dumont O, Piciotti M, Pascal G, et al. The effects of dietary α-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats. J Nutr. 1989;119:1880-1892. (Pubitemid 20063881)
5. Innis SM. Dietary (n-3) fatty acids and brain development. J Nutr. 2007;137:855-859. (Pubitemid 46596878)
6. Tozuka Y, Wada E, Wada K. "Bio-communication" between mother and offspring: lessons from animals and new perspectives for brain science. J Pharmacol Sci. 2009;110:127-132.
7. Broadhurst CL, Cunnane SC, Crawford MA. Rift valley lake fish and shellfish provided brain-specific nutrition for early homo. Br J Nutr. 1998;79:3-21. (Pubitemid 28058590)
8. Helland IB, Smith L, Saarem K, Saugstad OD, Christian A. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics. 2003;111:e39-e44.
9. Chamberlain JG. The possible role of long-chain, omega-3 fatty acids in human brain phylogeny. Perspect Biol Med. 1996;39:436-445.
10. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Wilson RS, et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neur. 2003;160:940-946. (Pubitemid 36858352)
11. Neuringer M, Connor WE, Lin DS, Barstad L, Luck S. Biochemical and functional effects of prenatal and postnatal omega 3 fatty acid deficiency on retina and brain I rhesus monkeys. Proc Natl Acad Sci U S A. 1986;83:4021-4025. (Pubitemid 16062414)
12. Söderberg M, Edlund C, Kristensson K, Dallner G. Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids. 1991;26:421-425.
13. Horrobin DF. The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophr Res. 1998;30:193-208. (Pubitemid 28189552)
14. Cummings JL, Cole G. Alzheimer disease. JAMA. 2002;287:2335-2338. (Pubitemid 34493187)
15. Kalmijn S, Launer LJ, Ott A, Witteman JC, Hofman A, Breteler MM. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol. 1997;42:776-782. (Pubitemid 27481550)
16. Kalmijn S, van Boxtel MP, Ocké M, Verschuren WM, Kromhout D, Launer LJ. Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology. 2004;62:275-280. (Pubitemid 38167138)
17. Morris MC, Evans DA, Tangney CC, Bienias JL, Wilson RS. Fish consumption and cognitive decline with age in a large community study. Arch Neurol. 2005;62:1849-1853. (Pubitemid 41785078)
18. Calon F, Cole G. Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies. Prostaglandins Leukot Essent Fatty Acids. 2007;77:287-293. (Pubitemid 350198857)
19. Conquer JA, Tierney MC, Zecevic J, Bettger WJ, Fisher RH. Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids. 2000;35:1305-1312. (Pubitemid 32064179)
20. Cunnane SC, Plourde M, Stewart K, Crawford MA. Docosahexaenoic acid and shore-based diets in hominin encephalization: a rebuttal. Am J Hum Biol. 2007;19:578-581. (Pubitemid 47050092)
21. Tixier-Vidal A, Picart R, Loudes C, Bauman AF. Effects of polyunsaturated fatty acids and hormones on synaptogenesis in serum-free medium cultures of mouse fetal hypothalamic cells. Neuroscience. 1986;17:115-132. (Pubitemid 16149507)
22. Greiner RS, Moriguchi T, Hutton A, Slotnick BM, Salem N Jr. Rats with low levels of brain docosahexaenoic acid show impaired performance in olfactory-based and spatial learning tasks. Lipids. 1999;34:S239-S243.
23. Gamoh S, Hashimoto M, Sugioka K, Hossain MS, Hata N, Misawa Y, et al. Chronic administration of docosahexaenoic acid improves reference memory-related learning ability in young rats. Neuroscience. 1999;93:237-241. (Pubitemid 29290703)
24. Gamoh S, Hashimoto M, Hossain S, Masumura S. Chronic ad ministration of docosahexaenoic cid improves the performance of radial arm maze task in aged rats. Clin Exp Pharmacol Physiol. 2001;28:266-270. (Pubitemid 32250711)
25. Lauritzen I, Blondeau N, Heurteaux C, Widmann C, Romey G, Lazdunski M. Polyunsaturated fatty acids are potent neuroprotectors. EMBO J. 2000;19:1784-1793. (Pubitemid 30204390)
26. Hashimoto M, Hossain S, Shimada T, Sugioka K, Yamasaki H, Fujii Y, et al. Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. J Neurochem. 2002;81:1084-1091. (Pubitemid 34809291)
27. Hashimoto M, Tanabe Y, Fujii Y, Kikuta T, Shibata H, Shido O. Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid β-infused rats. J Nutr. 2005;135:549-555. (Pubitemid 40365217)
28. Calon F, Lim GP, Yang F, Morihara T, Teter B, Ubeda O, et al. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron. 2004;43:633-645. (Pubitemid 39179724)
29. Calderon F, Kim HY. Docosahexaenoic acid promotes neurite growth in hippocampal neurons. J Neurochem. 2004;90:979-988. (Pubitemid 39099980)
30. Denys A, Hichami A, Maume B, Khan NA. Docosahexaenoic acid modulates phorbol ester-induced activation of extracellular signal-regulated kinases 1 and 2 in NIH/3T3 cells. Lipids. 2001;36:813-818. (Pubitemid 32924109)
31. Wainwright PE, Huang YS, Coscina DV, Lévesque S, McCutcheon D. Brain and behavioral effects of dietary n-3 deficiency in mice: a three generational study. Dev Psychobiol. 1994;27:467-487. (Pubitemid 2162190)
32. Crawford MA. The early development and evolution of the human brain. Ups J Med Sci. 1990;48:43-78. (Pubitemid 20371740)
33. Delion S, Chalon S, Guilloteau D, Besnard JC, Durand G. α-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex. J Neurochem. 1996;66:1582-1591.
34. Favrelère S, Stadelmann-Ingrand S, Huguet F, De Javel D, Piriou A, Tallineau C, et al. Age-related changes in ethanolamine glycerophospholipid fatty acid levels in rat frontal cortex and hippocampus. Neurobiol Aging. 2000;21:653-660.
35. Nourooz-Zadeh J, Liu EH, Yhlen B, Anggård EE, Halliwell B. F4-isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer's disease. J Neurochem. 1999;72:734-740. (Pubitemid 29055237)
36. Björkhem I, Lütjohann D, Diczfalusy U, Ståhle L, Ahlborg G, Wahren J. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J Lipid Res. 1998;39:1594-1600. (Pubitemid 28377923)
37. Abad-Rodriguez J, Ledesma MD, Craessaerts K, Perga S, Medina M, Delacourte A, et al. Neuronal membrane cholesterol loss enhances amyloid peptide generation. J Cell Biol. 2004;167:953-960. (Pubitemid 39628117)
38. Suzuki H, Park SJ, Tamura M, Ando S. Effect of the long-term feeding of dietary lipids on the learning ability, fatty acid composition of brain stem phospholipids and synaptic membrane fluidity in adult mice: a comparison of sardine oil diet with palm oil diet. Mech Ageing Dev. 1998;16:119-128. (Pubitemid 28165639)
39. Moriguchi T, Greiner RS, Salem N Jr. Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. J Neurochem. 2000;75:2563-2573.
40. Steele M, Stuchbury G, Münch G. The molecular basis of the prevention of Alzheimer's disease through healthy nutrition. Exp Gerontol. 2007;42:28-36. (Pubitemid 44937827)
41. Floyd RA, Hensley K. Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol Aging. 2002;23:795-807.
42. Choi J, Levey AI, Weintraub ST, Rees HD, Gearing M, Chin LS, et al. Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J Biol Chem. 2004;279:13256-13264. (Pubitemid 38445905)
43. Migliore L, Fontana I, Trippi F, Colognato R, Coppedè F, Tognoni G, et al. Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients. Neurobiol Aging. 2005;26:567-573.
44. Hossain MS, Hashimoto M, Gamoh S, Masumura S. Antioxidative effects of docosahexaenoic acid in the cerebrum versus cerebellum and brainstem of aged hypercholesterolemic rats. J Neurochem. 1999;72:1133-1138. (Pubitemid 29085028)
45. Florent S, Malaplate-Armand C, Youssef I, Kriem B, Koziel V, Escanyé MC, et al. Docosahexaenoic acid prevents neuronal apoptosis induced by soluble amyloid-beta oligomers. J Neurochem. 2006;96:385-395.
46. Florent-Béchard S, Malaplate-Armand C, Koziel V, Kriem B, Olivier JL, Pillot T, et al. Towards a nutritional approach for prevention of Alzheimer's disease: biochemical and cellular aspects. J Neurol Sci. 2007;262:27-36. (Pubitemid 47398892)
47. Cao DH, Xu JF, Xue RH, Zheng WF, Liu ZL. Protective effect of chronic ethyl docosahexaenoate administration on brain injury in ischemic gerbils. Pharmacol Biochem Behav. 2004;79:651-659.
48. Okada M, Amamoto T, Tomonaga M, Kawachi A, Yazawa K, Mine K, et al. The chronic administration of docosahexaenoic acid reduces the spatial cognitive deficit following transient forebrain ischemia in rats. Neuroscience. 1996;71:17-25. (Pubitemid 26042868)
49. Green P, Glozman S, Weiner L, Yavin E. Enhanced free radical scavenging and decreased lipid peroxidation in the rat fetal brain after treatment with ethyl docosahexaenoate. Biochim Biophys Acta. 2001;1532:203-212. (Pubitemid 32706440)
50. Yavin E, Brand A, Green P. Docosahexaenoic acid abundance in the brain: a biodevice to combat oxidative stress. Nutr Neurosci. 2002;5:149-157. (Pubitemid 34568212)
51. Lukiw WJ, Cui JG, Marcheselli VL, Bodker M, Botkjaer A, Gotlinger K, et al. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest. 2005;115:2774-2783. (Pubitemid 41434404)
52. Brunkan AL, Goate AM. Presenilin function and γ-secretase activity. J Neurochem. 2005;93:769-792.
53. Mattson MP. Pathways towards and away from Alzheimer's disease. Nature. 2004;430:631-639. (Pubitemid 39061671)
54. Tully AM, Roche HM, Doyle R, Fallon C, Bruce I, Lawlor B, et al. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study. Br J Nutr. 2003;89:483-489. (Pubitemid 36582118)
55. Schaefer EJ, Bongard V, Beiser AS, Lamon-Fava S, Robins SJ, Au R, et al. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol. 2006;63:1545-1550. (Pubitemid 44748796)
56. Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T, Basun H, Faxén-Irving G, Garlind A, et al. ω-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol. 2006;63:1402-1408. (Pubitemid 44547551)
57. Boston PF, Bennett A, Horrobin DF, Bennett CN. Ethyl-EPA in Alzheimer's disease-a pilot study. Prostaglandins Leukot Essent Fatty Acids. 2004;71:341-346. (Pubitemid 39233559)
58. Kotani S, Sakaguchi E, Warashina S, Matsukawa N, Ishikura Y, Kiso Y, et al. Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neurosci Res. 2006;56:159-164. (Pubitemid 44374788)
59. Hardy J, Selkoe DJ. Therapeutics progress and problems on the road to the amyloid hypothesis of Alzheimer's disease. Science. 2002;297:353-356. (Pubitemid 34790756)
60. Nitta A, Fukuta T, Hasegawa T, Nabeshima T. Continuous infusion of β-amyloid protein into cerebral ventricle induces learning impairment and neuronal and morphological degeneration. Jpn J Pharmacol. 1997;73:51-57. (Pubitemid 27078010)
61. Oka J, Suzuki E, Goto N, Kameyama T. Endogenous GLP-1 modulates hippocampal activity in β-amyloid proteintreated rats. Neuroreport. 1999;10:2961-2964. (Pubitemid 29507761)
62. Hashimoto M, Hossain S, Shimada T, Shido O. Docosahexaenoic acid-induced protective effect against impaired learning in amyloid β-infused rats is associated with increased synaptosomal membrane fluidity. Clin Exp Pharmacol Physiol. 2006;33:934-939. (Pubitemid 44427316)
63. Freir DB, Holscher C, Herron CE. Blockade of long-term potentiation by β-amyloid peptides in the CA1 region of the rat hippocampus in vivo. J Neurophysiol. 2001;85:708-713. (Pubitemid 32147772)
64. McGahon BM, Martin DS, Horrobin DF, Lynch MA. Age-related changes in synaptic function: analysis of the effect of dietary supplementation with omega-3 fatty acids. Neuroscience. 1999;94:305-314. (Pubitemid 29457620)
65. Fujita S, Ikegaya Y, Nishikawa M, Nishiyama N, Matsuki N. Docosahexaenoic acid improves long-term potentiation attenuated by phospholipase A2 inhibitor in rat hippocampal slices. British J Pharmacol. 2001;132:1417-1422. (Pubitemid 32281029)
66. Minami M, Kimura S, Endo T, Hamaue N, Hirafuji M, Togashi H, et al. Dietary docosahexaenoic acid increases cerebral acetylcholine levels and improves passive avoidance performance in stroke-prone spontaneously hypertensive rats. Pharmacol Biochem Behav. 1997;58:1123-1129. (Pubitemid 28108225)
67. Ding Q, Dimayuga E, Keller JN. Oxidative damage, protein synthesis, and protein degradation in Alzheimer's disease. Curr Alzheimer Res. 2007;4:73-79.
68. Moreira PI, Zhu X, Liu Q, Honda K, Siedlak SL, Harris PL, et al. Compensatory responses induced by oxidative stress in Alzheimer disease. Biol Res. 2006;39:7-13. (Pubitemid 44027641)
69. Grundman M. Vitamin E and Alzheimer disease: the basis for additional clinical trials. Am J Clin Nutr. 2000;71:630S-636S.
70. Sung S, Yao Y, Uryu K, Yang H, Lee VM, Trojanowski JQ, et al. Early vitamin E supplementation in young but not aged mice reduces Aβ levels and amyloid deposition in a transgenic model of Alzheimer's disease. FASEB J. 2004;18:323-325.
71. Prasad MR, Lovell MA, Yatin M, Dhillon H, Markesberg WR. Regional membrane phospholipids alterations in Alzheimer's disease. Neurochem Res. 1998;23:81-88. (Pubitemid 28145695)
72. Akbar M, Calderon F, Wen Z, Kim HY. Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival. Proc Natl Acad Sci U S A. 2005;102:10858-10863. (Pubitemid 41105957)
73. Ximenes da Silva A, Lavialle F, Gendrot G, Guesnet P, Alessandri JM, Lavialle M. Glucose transport and utilization are altered in the brain of rats deficient in n-3 polyunsaturated fatty acids. J Neurochem. 2002;81:1328-1337. (Pubitemid 34809266)
74. Pifferi F, Roux F, Langelier B, Alessandri JM, Vancassel S, Jouin M, et al. (n-3) polyunsaturated fatty acid deficiency reduces the expression of both isoforms of the brain glucose transporter GLUT1 in rats. J Nutr. 2005;135:2241-2246. (Pubitemid 41298394)
75. Pifferi F, Jouin M, Alessandri JM, Haedke U, Roux F, Perrière N, et al. Guesnet P. n-3 Fatty acids modulate brain glucose transport in endothelial cells of the blood-brain barrier. Prostaglandins Leukot Essent Fatty Acids. 2007;77:279-286. (Pubitemid 350198862)
76. Pifferi F, Jouin M, Alessandri JM, Roux F, Perrière N, Langelier B, et al. n-3 long-chain fatty acids and regulation of glucose transport in two models of rat brain endothelial cells. Neurochem Int. 2010;56:703-710.
77. Hashimoto M, Hossain S, Yamasaki H, Yazawa K, Masumura S. Effects of eicosapentaenoic acid and docosahexaenoic acid on plasma membrane fluidity of aortic endothelial cells. Lipids. 1999;34:1297-1304. (Pubitemid 30044268)
78. Kalpouzos G, Chételat G, Baron JC, Landeau B, Mevel K, Godeau C, et al. Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging. Neurobiol Aging. 2009;30:112-124.
79. Kalpouzos G, Eustache F, de la Sayette V, Viader F, Chételat G, Desgranges B. Working memory and FDG-PET dissociate early and late onset Alzheimer disease patients. J Neurol. 2005;252:548-558. (Pubitemid 40768170)
80. Green KN, Martinez-Coria H, Khashwji H, Hall EB, Yurko- Mauro KA, Ellis L, et al. Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-β and tau pathology via a mechanism involving presenilin 1 levels. J Neurosci. 2007;27:4385-4395. (Pubitemid 46640724)
81. Oksman M, Iivonen H, Hogyes E, Amtul Z, Penke B, Leenders I, et al. Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on β-amyloid accumulation in APP/PS1 transgenic mice. Neurobiol Dis. 2006;23:563-572. (Pubitemid 44234092)
82. Lukiw WJ, Bazan NG. Docosahexaenoic acid and the aging brain. J Nutr. 2008;138:2510-2514.
83. Bazan NG. Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathol. 2005;15:159-166. (Pubitemid 40546172)
84. Farooqui AA, Horrocks LA. Phospholipase A2-generated lipid mediators in the brain: the good, the bad, and the ugly. Neuroscientist. 2006;12:245-260. (Pubitemid 43725834)
85. 2 in neuronal homeostasis and memory formation: implications for the pathogenesis of Alzheimer's disease. J Neural Transm. 2007;114:231-238.
86. Pomponi M, Di Gioia A, Bria P, Pomponi MF. Fatty aspirin: a new perspective in the prevention of dementia of Alzheimer's type? Curr Alzheimer Res. 2008;5:422-431.
87. Michel V, Bakovic M. Lipid rafts in health and disease. Biol Cell. 2007;99:129-140. (Pubitemid 46380925)
88. London E. Insights into lipid raft structure and formation from experiments in model membranes. Curr Opin Struct Biol. 2002;12:480-486.
89. Dietrich C, Bagatolli LA, Volovyk ZN, Thompson NL, Levi M, Jacobson K, et al. Lipid rafts reconstituted in model membranes. Biophys J. 2001;80:1417-1428. (Pubitemid 32182165)
90. Morishima-Kawashima M, Ihara Y. The presence of amyloid β-protein in the detergent-insoluble membrane compartment of human neuroblastoma cells. Biochemistry. 1998;37:15247-15253. (Pubitemid 28515984)
91. Simons K, Ikonen E. Functional rafts in cell membranes. Nature. 1997;387:569-572. (Pubitemid 27248754)
92. Yip CM, Elton EA, Darabie AA, Morrison MR, McLaurin J. Cholesterol, a modulator of membraneassociated Aβ-fibrillogenesis and neurotoxicity. J Mol Biol. 2001;311:723-734. (Pubitemid 32803731)
93. Hashimoto M, Hossain S, Agdul H, Shido O. Docosahexaenoic acid-induced amelioration on impairment of memory learning in amyloid β-infused rats relates to the decreases of amyloid β and cholesterol levels in detergent-insoluble membrane fractions. Biochim Biophys Acta. 2005;1738:91-98. (Pubitemid 43122134)
94. Shahdat H, Hashimoto M, Shimada T, Shido O. Synaptic plasma membrane-bound acetylcholinesterase activity is not affected by docosahexaenoic acid-induced decrease in membrane order. Life Sci. 2004;74:3009-3024. (Pubitemid 38402297)
95. Krebs MRH, Bromley EHC, Donald AM. The binding of thioflavin-T to amyloid fibrils: localisation and implications. J Struct Biol. 2005;149:30-37. (Pubitemid 40051399)
96. Hashimoto M, Shahdat HM, Yamashita S, Katakura M, Tanabe Y, Fujiwara H, et al. Docosahexaenoic acid disrupts in vitro amyloid β(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats. J Neurochem. 2008;107:1634-1646.
97. 1-42-induced toxicity in SHS5Y5 cells. J Neurochem. 2009;111:568-579.
98. (25-35)-induced neurotoxicity in SH-SY5Y cells. J Nutr Biochem. 2011;22:22-29.
99. McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, et al. Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol. 1999;46:860-866.
100. Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, et al. Aβ oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci. 2007;27:796-807. (Pubitemid 46174498)
101. Chui DH, Tanahashi H, Ozawa K, Ikeda S, Checler F, Ueda O, et al. Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation. Nat Med. 1999;5:560-564. (Pubitemid 29220216)
102. Johansson AS, Garlind A, Berglind-Dehlin F, Karlsson G, Edwards K, Gellerfors P, et al. Docosahexaenoic acid stabilizes soluble amyloid-β protofibrils and sustains amyloid-β-induced neurotoxicity in vitro. FEBS J. 2007;274:990-1000. (Pubitemid 46204418)
103. Koo EH, Lansbury PT Jr, Kelly JW. Amyloid diseases: Abnormal protein aggregation in neurodegeneration. Proc Natl Acad Sci U S A. 1999;96:9989-9990. (Pubitemid 29422496)
104. Khurana R, Ionescu-Zanetti C, Pope M, Li J, Nielson L, Ramírez-Alvarado M, et al. A general model for amyloid fibril assembly based on morphological studies using atomic force microscopy. Biophys J. 2003;85:1135-1144. (Pubitemid 36909675)
105. Kirkitadze MD, Condron MM, Teplow DB. Identification and characterization of key kinetic intermediates in amyloid betaprotein fibrillogenesis. J Mol Biol. 2001;312:1103-1119. (Pubitemid 32980329)
106. Stine WB Jr, Dahlgren KN, Krafft GA, LaDu MJ. In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis. J Biol Chem. 2003;278:11612-11622.
107. Bemporad F, Taddei N, Stefani M, Chiti F. Assessing the role of aromatic residues in the amyloid aggregation of human muscle acylphosphatase. Protein Sci. 2006;15:862-870.
108. Gazit E. A possible role for pi-stacking in the self-assembly of amyloid fibrils. FASEB J. 2002;16:77-83. (Pubitemid 34027953)
109. Barnham KJ, Haeffner F, Ciccotosto GD, Curtain CC, Tew D, Mavros C, et al. Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease β-amyloid. FASEB J. 2004;18:1427-1429. (Pubitemid 39561603)
110. Stillwell W, Wassall SR. Docosahexaenoic acid: membrane properties of a unique fatty acid. Chem Phys Lipids. 2003;126:1-27. (Pubitemid 37297962)
111. Pilitsis JG, Diaz FG, Wellwood JM, Oregan MH, Fairfax MR, Phillis JW, et al. Quantification of free fatty acids in human cerebrospinal fluid. Neurochem Res. 2001;26:1265-1270. (Pubitemid 34184024)
112. Nakazawa K, Quirk MC, Chitwood RA, Watanabe M, Yeckel MF, Sun LD, et al. Receptors in associative memory recall requirement for hippocampal CA3 NMDA. Science. 2002;297:211-217.
113. Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA, et al. Neurogenesis in the adult human hippocampus. Nat Med. 1998;4:1313-1317. (Pubitemid 28512114)
114. Bedard A, Parent A. Evidence of newly generated neurons in the human olfactory bulb. Brain Res Dev Brain Res. 2004;151:159-168. (Pubitemid 38887743)
115. Shors TJ, Miesegaes G, Beylin A, Zhao M, Rydel T, Gould E. Neurogenesis in the adult is involved in the formation of trace memories. Nature. 2001;410:372-375.
116. Drapeau E, Mayo W, Aurousseau C, LeMoal M, Piazza PV, Abrous DN. Spatial memory performances of aged rats in the water maze predict levels of hippocampal neurogenesis. Proc Natl Acad Sci U S A. 2003;100:14385-14390. (Pubitemid 37499246)
117. Kawakita E, Hashimoto M, Shido O. Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience. 2006;139:991-997.
118. Katakura M, Hashimoto M, Shahdat HM, Gamoh S, Okui T, Matsuzaki K, et al. Docosahexaenoic acid promotes neuronal differentiation by regulating basic helix-loop-helix transcription factors and cell cycle in neural stem cells. Neuroscience. 2009;160:651-660.
119. Conklin SM, Gianaros PJ, Brown SM, Yao JK, Hariri AR, Manuck SB, et al. Long-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adults. Neurosci Lett. 2007;421:209-212. (Pubitemid 46935357)
120. de la Presa, Owens S, Innis SM. Docosahexaenoic and arachidonic acid prevent a decrease in dopaminergic and serotoninergic neurotransmitters in frontal cortex caused by a linoleic and α-linolenic acid deficient diet in formula-fed piglets. J Nutr. 1999;129:2088-2093. (Pubitemid 29506390)
121. Tanabe Y, Hashimoto M, Sugioka K, Maruyama M, Fujii Y, Hagiwara R, et al. Improvement of spatial cognition with dietary docosahexaenoic acid is associated with an increase in Fos expression in rat CA1 hippocampus. Clin Exp Pharmacol Physiol. 2004;31:700-703. (Pubitemid 39540320)
122. Cole GM, Ma QL, Frautschy SA. Omega-3 fatty acids and dementia. Prostaglandins Leukot Essent Fatty Acids. 2009;81:213-221.